{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:50:34Z","timestamp":1787496634131,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111155","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T13:19:46Z","timestamp":1727702386000},"page":"111155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy"],"prefix":"10.1016","volume":"136","author":[{"given":"Randall D.","family":"Ordovich-Clarkson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Arteaga","family":"Pelayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"La Croix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macie","family":"Mumman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshanah","family":"Stukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reagan","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Meraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Bangura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooklyn","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Bamrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb","family":"Blake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.pnpbp.2024.111155_bb0005","doi-asserted-by":"crossref","first-page":"165893","DOI":"10.1016\/j.bbadis.2020.165893","article-title":"Metformin preferentially provides neuroprotection following cardiac ischemia\/reperfusion in non-diabetic rats","volume":"1866","author":"Benjanuwattra","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.arr.2017.08.003","article-title":"Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis","volume":"40","author":"Campbell","year":"2017","journal-title":"Ageing Res. Rev."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111155_bb0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresbull.2016.04.016","article-title":"Neuropharmacology of N,N-dimethyltryptamine","volume":"126","author":"Carbonaro","year":"2016","journal-title":"Brain Res. Bull."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111155_bb0020","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2215-0366(16)30065-7","article-title":"Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study","volume":"3","author":"Carhart-Harris","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111155_bb0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00213-017-4771-x","article-title":"Psilocybin with psychological support for treatment-resistant depression: six-month follow-up","volume":"235","author":"Carhart-Harris","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0030","first-page":"812","article-title":"Metformin restores the mitochondrial membrane potentials in association with a reduction in TIMM23 and NDUFS3 in MPP+-induced neurotoxicity in SH-SY5Y cells","volume":"18","author":"Chanthammachat","year":"2019","journal-title":"PubMed"},{"issue":"36","key":"10.1016\/j.pnpbp.2024.111155_bb0035","doi-asserted-by":"crossref","first-page":"14968","DOI":"10.1073\/pnas.1107411108","article-title":"Serotonin signaling is associated with lower amyloid- levels and plaques in transgenic mice and humans","volume":"108","author":"Cirrito","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111155_bb0040","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acschemneuro.2c00637","article-title":"Shared and distinct brain regions targeted for immediate early gene expression by ketamine and psilocybin","volume":"14","author":"Davoudian","year":"2023","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2020.11.013","article-title":"Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig","volume":"42","author":"Donovan","year":"2021","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fnmol.2020.00084","article-title":"Metformin protects from rotenone\u2013induced nigrostriatal neuronal death in adult mice by activating AMPK-FOXO3 signaling and mitigation of angiogenesis","volume":"13","author":"El-Ghaiesh","year":"2020","journal-title":"Front. Mol. Neurosci."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111155_bb0060","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1046\/j.1460-9568.2000.00130.x","article-title":"In vivo neurogenesis in the adult brain: regulation and functional implications","volume":"12","author":"Fuchs","year":"2000","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111155_bb0065","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1021\/acschemneuro.8b00186","article-title":"DARK classics in chemical neuroscience: psilocybin","volume":"9","author":"Geiger","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.117456","article-title":"Psilocybin exerts distinct effects on resting state networks associated with serotonin and dopamine in mice","volume":"225","author":"Grandjean","year":"2021","journal-title":"NeuroImage"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111155_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193031","article-title":"Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo","volume":"13","author":"Han","year":"2018","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111155_bb0080","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/0269881120959614","article-title":"Transcriptional regulation in the rat prefrontal cortex and hippocampus after a single administration of psilocybin","volume":"35","author":"Jefsen","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0085","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.neuropharm.2013.04.002","article-title":"Role of BDNF epigenetics in activity-dependent neuronal plasticity","volume":"76","author":"Karpova","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuropharm.2017.08.015","article-title":"Metformin lowers \u03b1-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Katila","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105120","article-title":"Metformin attenuates rotenone-induced oxidative stress and mitochondrial damage via the AKT\/Nrf2 pathway","volume":"148","author":"Katila","year":"2021","journal-title":"Neurochem. Int."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111155_bb0100","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","article-title":"Genetics of Parkinson\u2019s disease","volume":"30","author":"Lill","year":"2016","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.746797","article-title":"Transcranial direct current stimulation for Parkinson\u2019s disease: A systematic review and Meta-analysis","volume":"13","author":"Liu","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111155_bb0110","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2024.111155_bb0120","article-title":"Prevalence of Parkinson\u2019s disease across North America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Parkinson\u2019s Disease"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108415","article-title":"Metformin and fluoxetine improve depressive-like behavior in a murine model of Parkinso\u0144s disease through the modulation of neuroinflammation, neurogenesis and neuroplasticity","volume":"102","author":"Mendon\u00e7a","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2022.852003","article-title":"Alpha-Synuclein targeting therapeutics for Parkinson\u2019s disease and related Synucleinopathies","volume":"13","author":"Menon","year":"2022","journal-title":"Front. Neurol."},{"issue":"6","key":"10.1016\/j.pnpbp.2024.111155_bb0135","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111155_bb0140","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41429-020-0311-8","article-title":"Psilocybin: from ancient magic to modern medicine","volume":"73","author":"Nichols","year":"2020","journal-title":"J. Antibiot."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111155_bb0145","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1208\/s12248-012-9439-1","article-title":"Pharmacokinetics of levodopa, carbidopa, and 3-O-methyldopa following 16-hour Jejunal infusion of levodopa-carbidopa intestinal gel in advanced Parkinson\u2019s disease patients","volume":"15","author":"Nyholm","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179069518800508","article-title":"Psychoplastogens: A promising class of plasticity-promoting neurotherapeutics","volume":"12","author":"Olson","year":"2018","journal-title":"J. Exp. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111155_bb0155","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1021\/acs.biochem.1c00812","article-title":"Biochemical mechanisms underlying psychedelic-induced neuroplasticity","volume":"61","author":"Olson","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.676239","article-title":"Monoamine oxidase inhibitors: A review of their anti-inflammatory therapeutic potential and mechanisms of action","volume":"12","author":"Ostadkarampour","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"71","key":"10.1016\/j.pnpbp.2024.111155_bb0165","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111155_bb0170","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4103\/aian.AIAN_239_17","article-title":"Levodopa-induced dyskinesia: clinical features, pathophysiology, and medical management","volume":"20","author":"Pandey","year":"2017","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105278","article-title":"Identification of the 5-HT1A serotonin receptor as a novel therapeutic target in a C. Elegans model of Machado-Joseph disease","volume":"152","author":"Pereira-Sousa","year":"2021","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.pnpbp.2024.111155_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22020835","article-title":"A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111155_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108173","article-title":"Metformin regulates astrocyte reactivity in Parkinson\u2019s disease and normal aging","volume":"175","author":"Ryu","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neures.2019.12.017","article-title":"Neuroprotective effect of metformin on dopaminergic neurodegeneration and \u03b1-synuclein aggregation in C. Elegans model of Parkinson\u2019s disease","volume":"162","author":"Saewanee","year":"2021","journal-title":"Neurosci. Res."},{"issue":"16","key":"10.1016\/j.pnpbp.2024.111155_bb0195","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111155_bb0200","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3233\/JPD-191648","article-title":"The qualification of an enrichment biomarker for clinical trials targeting early stages of Parkinson\u2019s disease","volume":"9","author":"Stephenson","year":"2019","journal-title":"J. Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111155_bb0205","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1002\/2211-5463.12436","article-title":"Metformin treatment ameliorates diabetes-associated decline in hippocampal neurogenesis and memory via phosphorylation of insulin receptor substrate 1","volume":"8","author":"Tanokashira","year":"2018","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2018.00440","article-title":"Divergent effects of metformin on an inflammatory model of parkinson\u2019s disease","volume":"12","author":"Tayara","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"6633","key":"10.1016\/j.pnpbp.2024.111155_bb0215","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasti`city through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.pnpbp.2024.111155_bb0220","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.18632\/aging.100862","article-title":"C-Fos importance for brain development","volume":"7","author":"Velazquez","year":"2015","journal-title":"Aging"},{"key":"10.1016\/j.pnpbp.2024.111155_bb0225","series-title":"Parkinson Disease","author":"Zafar","year":"2023"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:04:41Z","timestamp":1745838281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624002239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":43,"alternative-id":["S0278584624002239"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111155","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing psilocybin to metformin as neuroprotective agents against Parkinson's dementia: A systematic review of evidence and efficacy","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111155"}}